The FDA has granted orphan drug designation to Plus Therapeutics’ injectable rad...
NICE previously rejected Leqembi and Kisunla for NHS coverage in August and Octo...
J&J's news about aticaprant's Phase III programme comes two months after Neumora...
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indi...
Closing the gap in health interventions between men and women could add $1tn to ...
How to ensure safety and quality in pharmaceutical facilities when using HPAPIs ...
Astellas Pharma and Yaskawa have agreed to form a JV that will focus on developi...
A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into inter...
While the company is in discussions to acquire SpringWorks, it did not elaborate...
The company is planning an NDA submission for the neuroendocrine tumour-targetin...
Project Optimus seeks to transform how doses are selected and optimised in oncol...
Tris Pharma previously announced data from another Phase III trial of cebranopad...
TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on ...
Novo Nordisk increases efforts to rebuff pressures from the compounding marketpl...
Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance ...
Callio Therapeutics has raised $187m in Series A financing round for achieving c...
